Hester Biosciences Ltd.

NSE: HESTERBIO | BSE: 524669 | ISIN: INE782E01017 | Industry: Pharmaceuticals
| Mid-range Performer
1815.2000 40.30 (2.27%)
NSE Apr 21, 2025 14:31 PM
Volume: 13,304
 

1815.20
2.27%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Standalone revenues grew 20% YoY in H1FY19 to | 80.8 crore on the back of 36% growth in the large animal segment to | 14.8 crore and addition of veterinary social business. The poultry segment grew 10% YoY in H1FY19 to | 62.3 crore EBITDA margins remained healthy at 38% in H1FY19. EBITDA grew 18% YoY in H1FY19 to | 30.5 crore Net profit grew 30% YoY to | 19.6 in H1FY19 crore mainly due to a...
Hester Biosciences Ltd. has gained 29.58% in the last 1 Month
More from Hester Biosciences Ltd.
Recommended